Jan 14, 2019
Social injustice is perpetuated when patients can't afford to participate in essential clinical research.
Jan 08, 2019
Although there’s never a bad time to make a positive commitment in your life, something about opening the calendar to January 1 feels like the right moment to set an intention.
Jan 03, 2019
Dr. Pesona Grace Lucksom's career journey has been shaped by a series of battles with hormones and their impact on women's health, and this is a fight she intends to win.
Jan 02, 2019
A deliberately stylish patient led me to wonder if any insight can be gleaned from our patients' clothing choices as a reflection of how they're navigating the experience of illness and recovery.
Subscribe to this column
ASCO Commentary provides an interactive platform for ASCO’s organizational leadership and senior staff to connect directly to ASCO’s membership and the wider oncology community.
Feb 21, 2018
Dr. Richard L. Schilsky describes ASCO's Targeted Agent and Profiling Utilization Registry (TAPUR) Study and similar independent studies worldwide.
Oct 28, 2016
Dr. Richard L. Schilsky outlines the Society's Target Agent and Profiling Utilization Registry (TAPUR) Study and similar international protocols. A global data sharing platform could greatly accelerate our ability to learn about new uses for currently approved targeted anticancer drugs.
Nov 02, 2015
Chief Medical Officer Dr. Richard L. Schilsky answers your questions about this exciting new opportunity in health care policy and advocacy.
Oct 26, 2015
Personalized cancer care is not a new concept, but its application has been enabled and enhanced by a far greater understanding of the biological underpinnings of cancer than ever existed before.
Nov 12, 2014
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. During the past six weeks I’ve had the opportunity to attend cancer meetings in four countries on three continents. In September, I represented ASCO at the annual meeting of the Chinese Society of Clinical Oncology (CSCO) in Xiamen,...
Feb 06, 2014
Meaningful Progress Against Gastric, Pancreatic, and Colorectal Cancers Reported at the 2014 Gastrointestinal Cancers Symposium
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. I’ve been a regular attendee of the Gastrointestinal Cancers Symposium since it began 11 years ago. This year’s meeting was among the very best with record attendance, superb educational talks and keynote lectures, multidisciplinary...